Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn, about a recent article by Rammdeep Saini, published in Canadian Journal of Kidney Health and Disease, adding:
“Erythropoiesis-stimulating agents (ESAs) are commonly used to manage chronic kidney disease (CKD) associated anemia.
There is a paucity of clear guidelines on their use in patients with CKD and with history of stroke or malignancy.”
Title: A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease
Authors: Rammdeep Saini, Keigan More, Jo-Anne S. Wilson, David A. Clark, Amanda J. Vinson, David Collister, Mark Canney, and Karthik K. Tennankore
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering